Group One Trading’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-9,000
| Closed | -$19.9K | – | 8568 |
|
|
2023
Q2 | $19.9K | Buy |
9,000
+5,700
| +173% | +$11.8K | ﹤0.01% | 5999 |
|
|
2023
Q1 | $8.38K | Buy |
+3,300
| New | +$6.52K | ﹤0.01% | 6033 |
|
|
2022
Q4 | – | Sell |
-50,000
| Closed | -$129K | – | 8351 |
|
|
2022
Q3 | $129K | Hold |
50,000
| – | – | ﹤0.01% | 4542 |
|
|
2022
Q2 | $97K | Buy |
50,000
+33,300
| +199% | +$72.7K | ﹤0.01% | 5017 |
|
|
2022
Q1 | $50K | Sell |
16,700
-100
| -0.6% | -$376 | ﹤0.01% | 6101 |
|
|
2021
Q4 | $75K | Buy |
16,800
+4,500
| +37% | +$21.3K | ﹤0.01% | 5989 |
|
|
2021
Q3 | $60K | Sell |
12,300
-137,700
| -92% | -$759K | ﹤0.01% | 6398 |
|
|
2021
Q2 | $1.02M | Buy |
150,000
+58,400
| +64% | +$472K | ﹤0.01% | 3395 |
|
|
2021
Q1 | $647K | Buy |
91,600
+51,200
| +127% | +$369K | ﹤0.01% | 3739 |
|
|
2020
Q4 | $253K | Buy |
40,400
+20,300
| +101% | +$119K | ﹤0.01% | 3884 |
|
|
2020
Q3 | $109K | Sell |
20,100
-77,900
| -79% | -$386K | ﹤0.01% | 4139 |
|
|
2020
Q2 | $512K | Hold |
98,000
| – | – | ﹤0.01% | 2612 |
|
|
2020
Q1 | $309K | Buy |
98,000
+91,100
| +1,320% | +$336K | ﹤0.01% | 2405 |
|
|
2019
Q4 | $28K | Buy |
6,900
+200
| +3% | +$694 | ﹤0.01% | 4253 |
|
|
2019
Q3 | $29K | Buy |
+6,700
| New | +$26.8K | ﹤0.01% | 4224 |
|
|
2019
Q1 | – | Sell |
-300
| Closed | -$2K | – | 5515 |
|
|
2018
Q4 | $2K | Sell |
300
-500
| -63% | -$3.8K | ﹤0.01% | 4676 |
|
|
2018
Q3 | $8K | Buy |
800
+300
| +60% | +$3.03K | ﹤0.01% | 4729 |
|
|
2018
Q2 | $5K | Sell |
500
-1,200
| -71% | -$13.6K | ﹤0.01% | 4815 |
|
|
2018
Q1 | $22K | Sell |
1,700
-38,600
| -96% | -$575K | ﹤0.01% | 4055 |
|
|
2017
Q4 | $721K | Sell |
40,300
-37,900
| -48% | -$791K | 0.01% | 1958 |
|
|
2017
Q3 | $1.96M | Buy |
78,200
+56,500
| +260% | +$1.32M | 0.02% | 1061 |
|
|
2017
Q2 | $523K | Sell |
21,700
-119,200
| -85% | -$2.64M | 0.01% | 1940 |
|
|
2017
Q1 | $2.71M | Buy |
140,900
+138,400
| +5,536% | +$2.18M | 0.03% | 673 |
|
|
2016
Q4 | $39K | Buy |
2,500
+500
| +25% | +$6.49K | ﹤0.01% | 3401 |
|
|
2016
Q3 | $26K | Sell |
2,000
-9,000
| -82% | -$119K | ﹤0.01% | 3690 |
|
|
2016
Q2 | $153K | Buy |
+11,000
| New | +$162K | ﹤0.01% | 2588 |
|
|
2014
Q3 | – | Sell |
-167
| Closed | -$4K | – | 5546 |
|
|
2014
Q2 | $4K | Sell |
167
-75
| -31% | -$2.45K | ﹤0.01% | 4859 |
|
|
2014
Q1 | $9K | Buy |
242
+167
| +223% | +$6.6K | ﹤0.01% | 4641 |
|
|
2013
Q4 | $3K | Hold |
75
| – | – | ﹤0.01% | 4993 |
|
|
2013
Q3 | $3K | Sell |
75
-1,133
| -94% | -$40.6K | ﹤0.01% | 4911 |
|
|
2013
Q2 | $44K | Buy |
+1,208
| New | +$51.8K | ﹤0.01% | 3532 |
|
Group One Trading's PRTK Position: Q2 2023 in Review
Group One Trading sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2023, closing a stake of 33,812 shares — an estimated $70.1K sold.
Group One Trading first reported a position in PRTK in Q2 2013 and held it in 21 quarters. The position peaked at $882K in Q4 2020. 66 funds tracked by Wall St. Rank hold PRTK as of Q2 2023.
- Group One Trading reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
- Group One Trading sold 33,812 Paratek Pharmaceuticals, Inc. shares in Q2 2023, an estimated $70.1K.
- Group One Trading first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and held it in 21 quarters.
- Group One Trading's Paratek Pharmaceuticals, Inc. position peaked at $882K in Q4 2020.
- 66 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2023.
Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.